For: |
Kim TI. Chemopreventive drugs: Mechanisms |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i14/3835.htm |
Number | Citing Articles |
1 |
Marie Daugan, Amélie Dufaÿ Wojcicki, Benoit d’Hayer, Vincent Boudy. Metformin: An anti-diabetic drug to fight cancer. Pharmacological Research 2016; 113: 675 doi: 10.1016/j.phrs.2016.10.006
|
2 |
Youran Li, Yifan Lu, Minna Wu, Hao Wang, Yuxia Gong, Yunfei Gu. Neogambogic acid suppresses characteristics and growth of colorectal cancer stem cells by inhibition of DLK1 and Wnt/β-catenin pathway. European Journal of Pharmacology 2022; 929: 175112 doi: 10.1016/j.ejphar.2022.175112
|
3 |
Jeffrey H. Wimsatt, Caitlin Montgomery, Laurel S. Thomas, Charity Savard, Rachel Tallman, Kim Innes, Nezar Jrebi. Assessment of a mouse xenograft model of primary colorectal cancer with special reference to perfluorooctane sulfonate. PeerJ 2018; 6: e5602 doi: 10.7717/peerj.5602
|
4 |
Basil Rigas, George J. Tsioulias. The Evolving Role of Nonsteroidal Anti-Inflammatory Drugs in Colon Cancer Prevention: A Cause for Optimism. Journal of Pharmacology and Experimental Therapeutics 2015; 353(1): 2 doi: 10.1124/jpet.114.220806
|
5 |
Maram H. Zahra, Said M. Afify, Ghmkin Hassan, Hend M. Nawara, Kazuki Kumon, Akimasa Seno, Masaharu Seno. Metformin suppresses self‐renewal and stemness of cancer stem cell models derived from pluripotent stem cells. Cell Biochemistry and Function 2021; 39(7): 896 doi: 10.1002/cbf.3661
|
6 |
Tina Fransgaard, Lau Caspar Thygesen, Ismail Gögenur. Comment on: Need for Differentiating Diabetes-Specific Mortality from Total Mortality when Comparing Metformin with Insulin Regarding Cancer Survival. Annals of Surgical Oncology 2017; 24(S3): 615 doi: 10.1245/s10434-017-6177-8
|
7 |
Anna Maria Mileo, Paola Nisticò, Stefania Miccadei. Polyphenols: Immunomodulatory and Therapeutic Implication in Colorectal Cancer. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.00729
|
8 |
Jae Hyun Kim, Kyoung Jin Lee, Yoojeong Seo, Ji-Hee Kwon, Jae Pil Yoon, Jo Yeon Kang, Hyun Jung Lee, Soo Jung Park, Sung Pil Hong, Jae Hee Cheon, Won Ho Kim, Tae Il Kim. Effects of metformin on colorectal cancer stem cells depend on alterations in glutamine metabolism. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-017-18762-4
|
9 |
Yoojeong Seo, Janghyun Kim, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Won Ho Kim, Tae Il Kim. Metformin Suppresses Cancer Stem Cells through AMPK Activation and Inhibition of Protein Prenylation of the Mevalonate Pathway in Colorectal Cancer. Cancers 2020; 12(9): 2554 doi: 10.3390/cancers12092554
|
10 |
Samuel Fernández-Tomé, Fei Xu, Yanhui Han, Blanca Hernández-Ledesma, Hang Xiao. Inhibitory Effects of Peptide Lunasin in Colorectal Cancer HCT-116 Cells and Their Tumorsphere-Derived Subpopulation. International Journal of Molecular Sciences 2020; 21(2): 537 doi: 10.3390/ijms21020537
|
11 |
Seyed Mostafa Parizadeh, Reza Jafarzadeh-Esfehani, Seyed Mahdi Hassanian, Seyed Mohammad Reza Parizadeh, Samaneh Vojdani, Maryam Ghandehari, Anahita Ghazaghi, Majid Khazaei, Soodabeh Shahidsales, Majid Rezayi, Fereshteh Asgharzadeh, Majid Ghayour-Mobarhan, Gordon A. Ferns, Amir Avan. Targeting cancer stem cells as therapeutic approach in the treatment of colorectal cancer. The International Journal of Biochemistry & Cell Biology 2019; 110: 75 doi: 10.1016/j.biocel.2019.02.010
|
12 |
Ling Ding, Yuning Yang, Qin Lu, Dongfeng Qu, Parthasarathy Chandrakesan, Hailan Feng, Hong Chen, Xuzheng Chen, Zhuhui Liao, Jian Du, Zhiyun Cao, Nathaniel Weygant. Bufalin Inhibits Tumorigenesis, Stemness, and Epithelial–Mesenchymal Transition in Colorectal Cancer through a C-Kit/Slug Signaling Axis. International Journal of Molecular Sciences 2022; 23(21): 13354 doi: 10.3390/ijms232113354
|